Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ARVN
Stock Latest News
The Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
11d ago
AZN
LLY
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
PFE
ALGS
Premium
The Fly
Arvinas price target lowered to $12 from $48 at Morgan Stanley
15d ago
PFE
ARVN
Premium
The Fly
Arvinas price target lowered to $32 from $57 at Guggenheim
15d ago
ARVN
Premium
Ratings
Buy Rating for Arvinas Holding Company Amid Promising VERITAC-2 Trial Results and Potential Market Edge
15d ago
ARVN
Premium
The Fly
Arvinas downgraded to Neutral from Buy at Goldman Sachs
16d ago
ARVN
Premium
The Fly
PepsiCo downgraded, HubSpot upgraded: Wall Street’s top analyst calls
16d ago
VZ
COF
Premium
The Fly
Wedbush cuts Arvinas to Neutral as VERITAC-2 shows monotherapy strategy limited
16d ago
ARVN
Premium
The Fly
Arvinas price target lowered to $20 from $82 at BMO Capital
16d ago
ARVN
Premium
Ratings
Cautious Outlook on Arvinas Holding: Hold Rating Maintained Amid Mixed VERITAC-2 Trial Results
16d ago
ARVN
Premium
The Fly
Arvinas downgraded to Neutral from Outperform at Wedbush
16d ago
ARVN
Premium
The Fly
Arvinas price target lowered to $26 from $60 at Wells Fargo
16d ago
ARVN
Premium
The Fly
BofA lowers Arvinas price target to $28, calls selloff ‘overdone’
16d ago
ARVN
Premium
Ratings
Arvinas Holding Company: Promising ESR1m Subgroup Results and Strong Financial Position Support Buy Rating
16d ago
ARVN
Premium
Ratings
Arvinas Holding’s Promising Phase 3 Results and Strategic Focus Support Buy Rating
16d ago
ARVN
Premium
Ratings
Arvinas Holding Company: Strategic Positioning and Market Opportunities Amidst Challenges
16d ago
ARVN
Premium
Ratings
Arvinas Holding Company: Hold Rating Due to VERITAC-2 Trial Underperformance and Limited Market Uptake Potential
17d ago
ARVN
Premium
The Fly
Arvinas price target lowered to $10 from $19 at Citi
17d ago
ARVN
Premium
Company Announcements
Arvinas and Pfizer Announce Positive Phase 3 Trial Results
17d ago
8K
ARVN
Premium
Ratings
Promising Clinical Trial Results and Market Potential Drive Buy Rating for Arvinas Holding Company
17d ago
ARVN
Premium
The Fly
Arvinas downgraded at Oppenheimer after trial misses co-primary endpoint
17d ago
ARVN
Premium
The Fly
Arvinas downgraded to Perform from Outperform at Oppenheimer
17d ago
ARVN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
